CD8A and ovarian carcinoma: In this context, pDCs have also been associated with poor prognosis in ovarian carcinoma patients by inducing IL-10-producing CD8+ Treg cells and inhibition of T cell proliferation [292], resulting in an induction of angiogenesis through production of TNF and IL-8, as reported in human ovarian cancer [323].